Gavin is joined by Dr. Seth Berkley, former CEO of Gavi, the Vaccine Alliance, to discuss his new book, Fair Doses. Dr. Berkley reflects on the global impact of vaccines, the ongoing challenges to vaccine equity, and the lessons learned from leading initiatives such as COVAX during the COVID-19 pandemic. We also discuss the economics of vaccine distribution, the threat of misinformation, the promise of scientific innovation, and the future of global health preparedness, and a vision for str...
All content for The Lancet Voice is the property of The Lancet Group and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Gavin is joined by Dr. Seth Berkley, former CEO of Gavi, the Vaccine Alliance, to discuss his new book, Fair Doses. Dr. Berkley reflects on the global impact of vaccines, the ongoing challenges to vaccine equity, and the lessons learned from leading initiatives such as COVAX during the COVID-19 pandemic. We also discuss the economics of vaccine distribution, the threat of misinformation, the promise of scientific innovation, and the future of global health preparedness, and a vision for str...
Step counts and health outcomes - 7,000 or 10,000?
The Lancet Voice
27 minutes
3 months ago
Step counts and health outcomes - 7,000 or 10,000?
Where did the 10,000 steps recommendation come from? Why has it proven so stubborn? What's the science behind the new recommendations? How strong is the evidence? Professor Melody Ding joins Gavin to talk about her new systematic review published in The Lancet Public Health, examining the relationship between step counts and health outcomes. We also explore the challenges of measuring physical activity, the importance of inclusive research, and the role of environmental and policy interventio...
The Lancet Voice
Gavin is joined by Dr. Seth Berkley, former CEO of Gavi, the Vaccine Alliance, to discuss his new book, Fair Doses. Dr. Berkley reflects on the global impact of vaccines, the ongoing challenges to vaccine equity, and the lessons learned from leading initiatives such as COVAX during the COVID-19 pandemic. We also discuss the economics of vaccine distribution, the threat of misinformation, the promise of scientific innovation, and the future of global health preparedness, and a vision for str...
